About the ABPI

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

The full report, “Making the UK a science superpower” is published today by WPI Strategy and is available here. You are welcome to embed a link to the report in your copy.

The report was commissioned by the Association of the British Pharmaceutical Industry and supported by eight of the UK’s biggest industry groups, but represents the independent analysis of the author.

The industry leaders and organisations supporting the report and its call on the Chancellor are:  

  • Dr Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry
  • Julian David, CEO, Tech UK
  • Paul Everitt, CEO, ADS Group
  • Nick Shave, Chair, UKspace
  • Rain Newton-Smith, Chief Economist, Confederation of British Industry
  • Ben Fletcher, Executive Director, Make UK
  • Peter Ellingworth, CEO, Association of British Heath-tech Industries
  • Ian Wright, CEO, Food and Drink Federation

Media enquiries

+44 (0) 20 7747 7147​​